| |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Dec 5/23 | Dec 4/23 | Durkacz, Anthony John | Indirect Ownership | Multiple Voting Shares Class A | 16 - Acquisition under a prospectus exemption | 12 | $1.90 |
Dec 5/23 | Dec 4/23 | Saeed, Zeeshan | Indirect Ownership | Multiple Voting Shares Class A | 16 - Acquisition under a prospectus exemption | 12 | $1.90 |
Sign up or login above to see all SEDI filings within the past 6 months. |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Dec 5/23 | Dec 4/23 | Durkacz, Anthony John | Indirect Ownership | Multiple Voting Shares Class A | 16 - Acquisition under a prospectus exemption | 12 | $1.90 |
Dec 5/23 | Dec 4/23 | Saeed, Zeeshan | Indirect Ownership | Multiple Voting Shares Class A | 16 - Acquisition under a prospectus exemption | 12 | $1.90 |
Sign up or login above to see all SEDI filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. |
Competitors with Recent Insider Filings |
Fennec Pharmaceuticals (T:FRX*CA) |
Satellos Bioscience (T:MSCL*CA) |
XORTX Therapeutics (V:XRX*CA) |